Regulus Therapeutics
RGLS
#7307
Rank
C$0.80 B
Marketcap
C$11.67
Share price
0.00%
Change (1 day)
447.81%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): C-$1.02

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.04. In 2024 the company made an earnings per share (EPS) of C-$1.24.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$1.02-18.09%
2024C-$1.24
2022C-$2.66-43.12%
2021C-$4.68-40.55%
2020C-$7.87-50%
2019C-$15.73-80.36%
2018C-$80.11-57.8%
2017C-$189.82-28.66%
2016C-$266.0642.2%
2015C-$187.10-14.84%
2014C-$219.72156%
2013C-$85.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.83-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$3.38-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.18-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$4.12-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
C-$0.54-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.34-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA